Search results for "SYNDROME CORONAVIRUS"

showing 10 items of 552 documents

World Tuberculosis Day 2021 Theme - 'THE CLOCK IS TICKING' - and the world is running out of time to deliver the United Nations General Assembly comm…

2021

Microbiology (medical)2019-20 coronavirus outbreakEconomic growthTuberculosisUnited NationsCoronavirus disease 2019 (COVID-19)General assemblySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Infectious and parasitic diseasesRC109-216Political sciencePandemicwc_505medicineHumansTuberculosisPandemicswa_105SARS-CoV-2COVID-19General Medicinemedicine.diseaseCoronavirusInfectious Diseaseswf_200Theme (narrative)
researchProduct

Lessons from the COVID-19 Pandemic—Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe’s Public Health Systems

2020

Microbiology (medical)2019-20 coronavirus outbreakEconomic growthmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Public healthCOVID-19General Medicinelcsh:Infectious and parasitic diseasesInfectious DiseasesSettore MED/38 - PEDIATRIA GENERALE E SPECIALISTICAPreparednessPolitical sciencePandemicmedicinelcsh:RC109-216International Journal of Infectious Diseases
researchProduct

Oral antiseptics against coronavirus: in-vitro and clinical evidence

2021

Background Angiotensin converting enzyme II (ACE2) is the cellular receptor for SARS-CoV-2, so ACE2-expressing cells can act as target cells and are susceptible to infection. ACE2 receptors are highly expressed in the oral cavity so this may be a potential high-risk route for SARS-CoV-2 infection. Furthermore, the virus can be detected in saliva, even before COVID-19 symptoms appear, with the consequent high risk of virus transmission in asymptomatic/pre-symptomatic patients. Reducing oral viral load could lead to a lower risk of transmission via salivary droplets or aerosols and therefore contribute to the control of the pandemic. Aim To evaluate the available evidence testing the in vitro…

Microbiology (medical)2019-20 coronavirus outbreakmedicine.medical_specialtySalivaCoronavirus disease 2019 (COVID-19)coronavirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)virusesMouthwashesCetylpyridiniumReviewmedicine.disease_causeLower riskViruslaw.inventionoral antisepticsRandomized controlled triallawInternal medicinemedicineHumansSalivaLetter to the EditorPandemicsPovidone-IodineCoronavirusMouthSARS-CoV-2Transmission (medicine)business.industryCOVID-19Hydrogen PeroxideGeneral MedicineViral LoadVirologyIn vitroCOVID-19 Drug TreatmentCoronavirusoral rinseInfectious DiseasesSystematic reviewClinical evidenceAnti-Infective Agents LocalCoronavirus InfectionsbusinessViral loadJournal of Hospital Infection
researchProduct

Initial viral load and decay kinetics of SARS-CoV-2 lineage B.1.1.7 in the upper respiratory tract of adults and children

2021

We read with interest the systematic review published by Walsh et al. in the Journal of Infection,1 focusing on the dynamics of SARS-CoV-2 RNA at the upper respiratory tract (URT). In this context, a novel SARS-CoV-2 variant lineage (B.1.1.7), first detected in the UK at the end of 2020 has transmission advantage over other lineages.2 Increased transmissibility of the B.1.1.7 variant has been linked to enhanced ACE2 affinity3 allegedly resulting in higher viral loads in URT, an observation that has been reported in some,3, 4, 5, 6 but not all7 large series published to date. In addition, longer duration of SARS-CoV-2 RNA shedding in URT has been reported in individuals infected by the B.1.1…

Microbiology (medical)Adult2019-20 coronavirus outbreakLineage (genetic)Time FactorsCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralBiologySeverity of Illness IndexBetacoronavirusFecesLimit of DetectionmedicineHumansChildLetter to the EditorAsymptomatic InfectionsPandemicsNoseSARS-CoV-2SputumCOVID-19Viral LoadVirologyVirus SheddingInfectious Diseasesmedicine.anatomical_structureRNA ViralCoronavirus InfectionsViral loadRespiratory tract
researchProduct

Containment of a Large SARS-CoV-2 Outbreak Among Healthcare Workers in a Pediatric Intensive Care Unit.

2020

Objective Healthcare workers (HCWs) are particularly exposed SARS-CoV-2 because they are critical in preventing viral transmission and treating COVID-19 patients. Within HCWs, personnel of intensive care units (ICUs) are at the forefront of treating patients with a severe course of COVID-19 infection and therefore represent an extremely vulnerable group. Thus, our objective is to contribute to establish means of infection control protecting HCWs in the frontline of the current pandemic. Design An outbreak of SARS-CoV-2 was detected and contained in a pediatric ICU (PICU). The first positive case was identified with a point-of-care diagnostic system on site. Real-time PCR-based testing syste…

Microbiology (medical)AdultMalemedicine.medical_specialtyInfectious Disease Transmission Patient-to-ProfessionalSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Health PersonnelPneumonia ViralPsychological interventionIntensive Care Units PediatricHospitals UniversityTertiary Care Centers03 medical and health sciencesBetacoronavirusYoung Adult0302 clinical medicine030225 pediatricsIntensive careGermanyPandemicHealth caremedicineInfection controlHumansPediatrics Perinatology and Child Health030212 general & internal medicinePandemicsPediatric intensive care unitInfection Controlbusiness.industrySARS-CoV-2virus diseasesOutbreakCOVID-19Middle AgedInfectious DiseasesPediatrics Perinatology and Child HealthEmergency medicineQuarantineFemalebusinessCoronavirus InfectionsThe Pediatric infectious disease journal
researchProduct

Facepiece filtering respirators with exhalation valve should not be used in the community to limit SARS-CoV-2 diffusion.

2020

Microbiology (medical)Aerosols2019-20 coronavirus outbreakbusiness.product_categoryCoronavirus disease 2019 (COVID-19)business.industryEpidemiologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AcousticsExhalationCOVID-19Infectious DiseasesResidence CharacteristicsCOVID-19 SARS-CoV-2 FFR medical mask Facepice filtering respiratorsMedicineHumansEquipment FailureRespiratorRespiratory Protective DevicesbusinessLetter to the EditorInfection control and hospital epidemiology
researchProduct

Impact of the SARS-CoV-2 Pandemic in Candidaemia, Invasive Aspergillosis and Antifungal Consumption in a Tertiary Hospital

2021

In addition to the increase in fungal infections that has been observed in the last few decades, it has been reported that severe clinical COVID-19 can increase the risk of invasive fungal infections. The main objective of this study was to evaluate if there had been an increase in candidaemia and invasive pulmonary aspergillosis (IPA) cases since the onset of the SARS-CoV-2 pandemic. Data were retrospectively collected from April 2019 to March 2021, from patients admitted to Consorcio Hospital General Universitario de Valencia (Spain). A total of 152 candidaemia cases (56 of which were due to Candida auris) and 108 possible IPA cases were detected. A great increase in candidaemia cases was…

Microbiology (medical)Antifungalmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)medicine.drug_classQH301-705.5Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)IFIPlant ScienceAspergillosisArticle03 medical and health sciences0302 clinical medicineInternal medicinePandemicmedicinecandidaemiaaspergillosis030212 general & internal medicineBiology (General)skin and connective tissue diseasesEcology Evolution Behavior and SystematicsVoriconazole0303 health sciences030306 microbiologybusiness.industryMortality rateisavuconazoleCOVID-19medicine.diseaserespiratory tract diseasesCandida aurisbusinessantifungalsmedicine.drugJournal of Fungi
researchProduct

Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty® COVID-19 vaccine

2021

ABSTRACTObjectivesThere is scarce information as to the durability of immune responses elicited by the Comirnaty® COVID-19 vaccine in nursing home residents. Here, we assessed SARS-CoV-2-Spike (S)-targeted antibody and functional T cell responses at around 6 months after complete vaccination.MethodsThe sample comprised 46 residents (34 females; age, 60-100 years), of whom 10 had COVID-19 prior to vaccination. Baseline (median of 17.5 days after vaccination) and follow-up (median, 195 days) plasma specimens were available for quantitation of SARS-CoV-2-S antibodies and enumeration of SARS-CoV-2-S-reactive IFN-γ CD4+ and CD8+ T cells by flow cytometry.ResultsIn total, 44/45 participants had d…

Microbiology (medical)medicine.diagnostic_testbiologyCoronavirus disease 2019 (COVID-19)business.industryT cellSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Flow cytometryVaccinationInfectious Diseasesmedicine.anatomical_structureImmune systemImmunologymedicinebiology.proteinAntibodybusinessCD8Journal of Infection
researchProduct

Post-COVID functional limitations on daily living activities are associated with symptoms experienced at the acute phase of SARS-CoV-2 infection and …

2022

Microbiology (medical)medicine.medical_specialty2019-20 coronavirus outbreakInfectious DiseasesActivities of daily livingMulticenter studyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Emergency medicinemedicinebusinessUnit (housing)Journal of Infection
researchProduct

Learning From Mistakes: The Role of Phages in Pandemics

2021

The misuse of antibiotics is leading to the emergence of multidrug-resistant (MDR) bacteria, and in the absence of available treatments, this has become a major global threat. In the middle of the recent severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic, which has challenged the whole world, the emergence of MDR bacteria is increasing due to prophylactic administration of antibiotics to intensive care unit patients to prevent secondary bacterial infections. This is just an example underscoring the need to seek alternative treatments against MDR bacteria. To this end, phage therapy has been proposed as a promising tool. However, further research in the field is mandatory to assure…

Microbiology (medical)medicine.medical_specialtyantibiotic resistancephage therapyPhage therapyPhage therapymedicine.drug_classMultidrug-resistant bacteriamedicine.medical_treatmentSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibioticslcsh:QR1-502multidrug-resistant bacteriaEmergent pathogenMicrobiologylcsh:Microbiologylaw.inventionAntibiotic resistancelawPandemicmedicineIntensive care medicinePublic healthbusiness.industryTreatment regimenPublic healthpublic healthIntensive care unitemergent pathogenPerspectivebusinessFrontiers in Microbiology
researchProduct